Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 87.97 million during the last session, with the company’s beta value hitting 1.43. At the close
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 62.86 million during the latest session, with the company’s beta value hitting 1.43. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
